ChemicalBook > CAS DataBase List > Doxorubicin IMpurity B

Doxorubicin IMpurity B

Doxorubicin IMpurity B Structure
Doxorubicin IMpurity B
  • CAS No.106401-68-7
  • Chemical Name:Doxorubicin IMpurity B
  • CBNumber:CB42674142
  • Molecular Formula:C29H34BrNO11
  • Formula Weight:652.48
  • MOL File:106401-68-7.mol
Doxorubicin IMpurity B Property
  • Boiling point 804.7±65.0 °C(Predicted)
  • Density 1.63±0.1 g/cm3(Predicted)
  • pka 7.51±0.60(Predicted)
  • FDA UNII 3Z1AE1LY2D
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal word
  • Hazard statements
  • Precautionary statements

Doxorubicin IMpurity B Chemical Properties,Usage,Production

  • Uses Doxorubicin Ketal Derivative is an impurity and a derivative compound of Doxorubicin. An antibacterial.
  • Uses (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, is the metabolite of Doxorubicin (D558000), which is a neoplasm inhibitor
Doxorubicin IMpurity B Preparation Products And Raw materials
Raw materials
Preparation Products
Global(34)Suppliers
  • Supplier:
    Standardpharm Co. Ltd.
  • Tel:86-714-3992388
  • Email:overseasales1@yongstandards.com
  • Country:United States
  • ProdList:14332
  • Advantage:58
  • Supplier:
    career henan chemical co
  • Tel:+86-0371-86658258<br/>+8613203830695
  • Email:factory@coreychem.com
  • Country:China
  • ProdList:29808
  • Advantage:58
  • Supplier: Guangzhou PI PI Biotech Inc
  • Tel:020-81716320<br/>+86-13602409664
  • Email:Sales@pipitech.com
  • Country:China
  • ProdList:3633
  • Advantage:55
  • Supplier: J & K SCIENTIFIC LTD.
  • Tel: 18210857532
  • Email:jkinfo@jkchemical.com
  • Country:China
  • ProdList:96815
  • Advantage:76
  • Supplier: ChemStrong Scientific Co.,Ltd
  • Tel:0755-0755-66853366<br/>13670046396
  • Email:sales@chem-strong.com
  • Country:China
  • ProdList:18146
  • Advantage:56
  • Supplier: BOC Sciences
  • Tel: 16314854226
  • Email:info@bocsci.com
  • Country:United States
  • ProdList:9923
  • Advantage:65
Doxorubicin IMpurity B Spectrum
106401-68-7, Doxorubicin IMpurity BRelated Search:
  • Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals
  • 杂质对照品
  • 标准品
  • 对照品-杂质对照品
  • C29H34BrNO11
  • 阿霉素杂质2(阿霉素EP杂质B)
  • (8S,10S)-10-(((2R,4S,5S,6S)-4-氨基-5-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-8-(2-溴- 1,1-二甲氧基乙基)-6,8,11-三羟基-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮 (多柔比星杂质)
  • 多柔比星杂质02(单体)
  • 盐酸多柔比星EP杂质B
  • DOXORUBICIN KETAL 杂质
  • 表柔比星溴缩酮
  • 阿霉素杂质B(EP)
  • 多柔比星EP杂质B
  • 阿霉素EP杂质B
  • 阿霉素杂质B
  • (8S,10S)-10-[(3-氨基-2,3,6-三脱氧-ALPHA-L-吡喃来苏己糖基)氧基]-8-(2-溴-1,1-二甲氧基乙基)-7,8,9,10-四氢-6,8,11-三羟基-1-甲氧基-5,12-并四苯醌
  • 多柔比星杂质B
  • 106401-68-7
  • (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione (Doxorubicin Impurity)
  • (8S,10S)-10[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
  • (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
  • Doxorubicin Hydrochloride EP Impurity B
  • Doxorubicin Ketal Derivative
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
  • Doxorubicin Ketal Impurity
  • Doxorubicin EP Impurity B
  • (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromo-1,1-dimethoxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
  • Doxorubicin Impurity 2(Doxorubicin EP Impurity B)
  • Doxorubicin Hydrochloride impurity B
  • (8S,10S)-10-[(3-AMino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-broMo-1,1-diMethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-5,12-naphthacenedione (Doxorubicin IMpurity)
  • Doxorubicin IMpurity B
  • (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione